Compare UFPT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFPT | NNNN |
|---|---|---|
| Founded | 1963 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 1996 | N/A |
| Metric | UFPT | NNNN |
|---|---|---|
| Price | $190.70 | $25.67 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $289.00 | N/A |
| AVG Volume (30 Days) | ★ 156.9K | 20.3K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.44 | N/A |
| EPS | ★ 8.75 | N/A |
| Revenue | ★ $602,797,000.00 | N/A |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $5.72 | N/A |
| P/E Ratio | ★ $21.95 | $446.57 |
| Revenue Growth | ★ 19.50 | N/A |
| 52 Week Low | $182.87 | $5.91 |
| 52 Week High | $274.93 | $55.65 |
| Indicator | UFPT | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 37.93 | 56.03 |
| Support Level | $185.32 | $19.53 |
| Resistance Level | $206.13 | $30.70 |
| Average True Range (ATR) | 7.89 | 2.11 |
| MACD | 1.51 | 0.52 |
| Stochastic Oscillator | 30.77 | 71.53 |
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.